1230 Novel imaging-based radiomics distinguishes radiation and immunotherapy induced pneumonitis in locally advanced NSCLC

1230 Novel imaging-based radiomics distinguishes radiation and immunotherapy induced pneumonitis in locally advanced NSCLC

Bibliographic Details
Main Authors:	Mohammadhadi Khorrami, Anant Madabhushi, Pradnya Patil, Nathan Pennell, Vidya Viswanathan, Lukas Delasos
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al
by: Pingfu Fu, et al.
Published: (2022-05-01)

Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
by: Paul Zarogoulidis, et al.
Published: (2022-01-01)

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer
by: Mohammadhadi Khorrami, et al.
Published: (2023-08-01)

1298 Radiomics features to predict immune checkpoint inhibitor-related pneumonitis (CIP) in NSCLC patients treated with immunotherapy
by: Young Kwang Chae, et al.
Published: (2023-11-01)

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab
by: Amit Gupta, et al.
Published: (2022-03-01)

Automation Radiomics in Predicting Radiation Pneumonitis (RP)
by: Sotiris Raptis, et al.
Published: (2023-07-01)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
by: Joshua E. Reuss, MD, et al.
Published: (2021-10-01)

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis Rate
by: Markus Stana, et al.
Published: (2023-03-01)

Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings
by: Abhishek Midya, et al.
Published: (2023-09-01)

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
by: Vivekanandan, S, et al.
Published: (2017)

37 Quantitative Lung Airway Morphology (QuaLM) features on chest CT scans are associated with response and overall survival in lung cancer patients treated with checkpoint inhibitors
by: Amit Gupta, et al.
Published: (2021-11-01)

Quantifying local heterogeneity via morphologic scale: Distinguishing tumoral from stromal regions
by: Andrew Janowczyk, et al.
Published: (2013-01-01)

Characterization of Chlorella sorokiniana, UTEX 1230
by: Alessandro Marco Lizzul, et al.
Published: (2018-04-01)

Re-evaluating the risk factors for radiation pneumonitis in the era of immunotherapy
by: Feihu Chen, et al.
Published: (2023-06-01)

Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
by: Chanon Puttanawarut, et al.
Published: (2022-02-01)

Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.
by: Gregory Penzias, et al.
Published: (2018-01-01)

CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
by: Bolin Song, et al.
Published: (2023-06-01)

The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study
by: Abdou Khadir Dia, et al.
Published: (2024-01-01)

Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics
by: Sevinj Yolchuyeva, et al.
Published: (2024-01-01)

A Novel Nodule Edge Sharpness Radiomic Biomarker Improves Performance of Lung-RADS for Distinguishing Adenocarcinomas from Granulomas on Non-Contrast CT Scans
by: Mehdi Alilou, et al.
Published: (2021-06-01)

Fiscalidad regia en León, 1230-1350
by: José M. Santamarta Luengos
Published: (2001-08-01)

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
by: Johan F. Vansteenkiste, MD, PhD, et al.
Published: (2024-03-01)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
by: Yuhei Kinehara, MD, PhD, et al.
Published: (2023-11-01)

Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC
by: Diego de Miguel‑Perez, et al.
Published: (2024-03-01)

The Landscape of Immunotherapy Resistance in NSCLC
by: Daniele Frisone, et al.
Published: (2022-04-01)

829 Spatial arrangement and density of tumor-infiltrating lymphocytes (TILs) predicts response to immunotherapy in head and neck squamous cell carcinoma patients
by: Pingfu Fu, et al.
Published: (2021-11-01)

Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review
by: Jie Huang, et al.
Published: (2023-01-01)

Immunotherapy and NSCLC: The Long and Winding Road
by: Antonio Rossi
Published: (2020-09-01)

Immunotherapy in NSCLC Patients with Brain Metastases
by: Silvia Buriolla, et al.
Published: (2022-06-01)

Erratum: The landscape of immunotherapy resistance in NSCLC
by: Frontiers Production Office
Published: (2023-04-01)

Recent Advances in Immunotherapy in Metastatic NSCLC.
by: Pranshu Bansal, et al.
Published: (2016-11-01)

1299 Radiomics features to predict tumor response and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy
by: Young Kwang Chae, et al.
Published: (2023-11-01)

Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study
by: Bin Xu, et al.
Published: (2023-10-01)

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC
by: Amine Bouhamama, et al.
Published: (2023-05-01)

A Combined-Radiomics Approach of CT Images to Predict Response to Anti-PD-1 Immunotherapy in NSCLC: A Retrospective Multicenter Study
by: Minghao Wu, et al.
Published: (2022-01-01)

Development and Validation of a Radiomics Nomogram Using Computed Tomography for Differentiating Immune Checkpoint Inhibitor-Related Pneumonitis From Radiation Pneumonitis for Patients With Non-Small Cell Lung Cancer
by: Qingtao Qiu, et al.
Published: (2022-04-01)

Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy
by: Taka-aki Hirose, et al.
Published: (2020-11-01)

Maurilio Pérez González (ed.), Lexicon latinitatis Medii aevi regni Legionis (s. viii-1230) imperfectum. Léxico latinorromance del reino de León (s. viii-1230)
by: Hélène Sirantoine
Published: (2012-11-01)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
by: Kim Melanie Kraus, et al.
Published: (2023-03-01)

GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis
by: A. Alarcon-Dionet, et al.
Published: (2024-01-01)